Indian drugmakers need more FDA approvals to maintain growth

02/16/2009 | Business Standard (India)

Indian pharmaceutical companies including Dr. Reddy's Laboratories and Sun Pharma would require at least 12 to 14 FDA approvals to achieve their 20% sales growth target in the U.S., according to a Credit Suisse report. Ranbaxy Laboratories, which is under investigation for manufacturing violations, needs 20 more approvals to hit the target this year, the report said.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN